Argent BioPharma Limited (RGTLF)
OTCMKTS
· Delayed Price · Currency is USD
0.1110
-0.0391 (-26.05%)
At close: May 22, 2025
Argent BioPharma Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Net Income | -22.62 | -17.53 | -20.82 | -20.35 | -15.87 | -19.36 | Upgrade
|
| Depreciation & Amortization | 1.91 | 1.29 | 0.75 | 0.14 | 0.49 | 0.48 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 3.15 | 4.98 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.34 | -1.34 | 1.39 | 0.57 | 0.55 | 5.12 | Upgrade
|
| Stock-Based Compensation | 3.64 | 3.64 | 2.66 | 0.52 | 1.65 | 0.85 | Upgrade
|
| Other Operating Activities | 8.75 | 0.66 | -1.17 | 0 | 4.7 | 2.01 | Upgrade
|
| Change in Accounts Receivable | -0.23 | -0.23 | 1.41 | 1.29 | -2.22 | 0.27 | Upgrade
|
| Change in Inventory | 0.49 | 0.49 | 0.48 | -0.97 | -0.47 | -0.26 | Upgrade
|
| Change in Accounts Payable | -1.64 | -1.64 | 0.19 | 1.63 | -0.82 | 0.94 | Upgrade
|
| Operating Cash Flow | -11.03 | -14.66 | -11.99 | -12.16 | -11.99 | -9.96 | Upgrade
|
| Capital Expenditures | -0.13 | -0.14 | -0.19 | -2.69 | -3.33 | -0.96 | Upgrade
|
| Cash Acquisitions | - | - | - | 0.15 | -0.29 | - | Upgrade
|
| Divestitures | - | - | - | - | -0.08 | -0.01 | Upgrade
|
| Investment in Securities | - | - | - | -0.16 | 0.3 | 0.01 | Upgrade
|
| Other Investing Activities | - | - | 0.8 | 1.59 | 2.45 | - | Upgrade
|
| Investing Cash Flow | -0.13 | -0.14 | 0.61 | -1.11 | -1.49 | -0.97 | Upgrade
|
| Long-Term Debt Issued | - | - | 7.16 | 0.06 | 5.75 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.24 | -0.2 | -0.26 | -0.26 | -0.18 | Upgrade
|
| Net Debt Issued (Repaid) | -0.25 | -0.24 | 6.96 | -0.2 | 5.49 | -0.18 | Upgrade
|
| Issuance of Common Stock | 5.69 | 15.94 | 3.09 | 10.7 | 12.76 | 11.43 | Upgrade
|
| Other Financing Activities | -0.03 | -0.44 | -0.32 | -0.76 | -1.2 | -0.79 | Upgrade
|
| Financing Cash Flow | 5.41 | 15.27 | 9.73 | 9.74 | 17.05 | 10.46 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.01 | -0 | - | -0.02 | -0.01 | -0.02 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | -0 | - | - | Upgrade
|
| Net Cash Flow | -5.76 | 0.46 | -1.65 | -3.55 | 3.56 | -0.48 | Upgrade
|
| Free Cash Flow | -11.16 | -14.8 | -12.18 | -14.85 | -15.32 | -10.92 | Upgrade
|
| Free Cash Flow Margin | -3771.39% | -1661.19% | -359.40% | -313.85% | -511.23% | -525.16% | Upgrade
|
| Free Cash Flow Per Share | -0.22 | -0.40 | -4.13 | -5.79 | -8.04 | -7.90 | Upgrade
|
| Cash Interest Paid | - | 0 | 0.26 | 0.03 | - | 0.14 | Upgrade
|
| Cash Income Tax Paid | - | - | 0 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -2 | -7.22 | -5.54 | -8.81 | -12.6 | -6.02 | Upgrade
|
| Unlevered Free Cash Flow | -1.98 | -6.91 | -5.37 | -8.67 | -12.37 | -5.94 | Upgrade
|
| Change in Net Working Capital | -3.06 | 0.44 | -0.91 | -2.92 | 3.72 | -0.74 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.